Cite
MLA Citation
Ami V. Desai et al.. “Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease.” Cancer, vol. 128, no. 15, 2022, pp. 2967–2977. http://access.bl.uk/ark:/81055/vdc_100159168430.0x00005a